Jagsonpal Pharma's Q1 Financial Report Shows Positive Trends in Profitability and Sales
Jagsonpal Pharmaceuticals, a smallcap company in the pharma industry, has shown positive performance in the quarter ending March 2024. With a significant improvement in key areas such as PBT, net sales, and operating profit, the company's financial report indicates a positive trend and potential for growth.
Jagsonpal Pharmaceuticals, a smallcap company in the pharma industry, has recently declared its financial results for the quarter ending March 2024. The company's stock has been given a 'Hold' call by MarketsMOJO.According to the financial report, Jagsonpal Pharma has shown positive performance in the quarter, with a score improvement from -16 to 6 in the last three months. This is a significant improvement and indicates a positive trend for the company.
One of the key factors contributing to this positive performance is the growth in Profit Before Tax less Other Income (PBT) for the quarter. At Rs 8.96 crore, it has grown by 74.1% compared to the average PBT of the previous four quarters, which was Rs 5.15 crore. This shows a strong upward trend in the company's profitability.
The company's net sales for the quarter also saw a significant increase, reaching Rs 61.44 crore, the highest in the last five quarters. This indicates a positive trend in sales for Jagsonpal Pharma.
Another positive aspect of the financial report is the increase in Operating Profit (PBDIT) for the quarter, which reached its highest at Rs 10.24 crore. This shows that the company's operations are becoming more efficient.
Jagsonpal Pharma's Operating Profit Margin for the quarter also saw a significant improvement, reaching its highest at 16.67%. This indicates that the company's efficiency has improved, leading to better profitability.
Overall, the company's financial report for the quarter ending March 2024 shows positive trends in key areas such as PBT, net sales, and operating profit. This is a promising sign for Jagsonpal Pharmaceuticals and its investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
